MNA Chairman of the Biotechnology Development Council said Mon. that the country has obtained the technical know-how for production of 10 new biopharmaceuticals, which will be produced and enter the market in two or three years. Mostafa Ghanei, Chairman of the Biotechnology Development Council, told Mehr News correspondent on Monday that in the ...

MNA Chairman of the Biotechnology Development Council said Wednesday that the country is planning to develop 30 new biopharmaceuticals in the future. Mostafa Ghanei, Chairman of the Biotechnology Development Council, said biopharmaceuticals in Iran are developed by Iranian scientists and experts, voicing the Councils support for the production ...

MNA Iranian biotech medicines exported to Russia have taken over the countrys market 100% and have replaced their American versions, according to National Talents Foundation. Meanwhile, Irans status in the field of knowledge-based and innovative economy has leaped 42 places in global indexes in 2016 and reached 78th place from 120th in 2014. Drug ...

Tasnim Iran will rank third in Asia in terms of production of biotech medicines within the next three years, a senior official at the office of the vice-president for science and technology affairs announced. Currently, the number of biotech medicines in the world market is 146, of which 20 are available in the Iranian market, Mostafa Qanei ...

May 29,The Iran Project An Iranian senior official has announced that the slamic Republic is a leading producer of biotechnological medicines at the regional level. Speaking about Irans status in the region in the field of biotech drugs, Mostafa Ghanei Deputy of Science and Technology and the Secretary of Biotech Development Headquarter said that ...